|Covalon Technologies Ltd -- Canada Stock|| |
CAD 4.5 0.13 2.97%
Co-Founder and Chief Science Officer
Dr. Valerio DiTizio serves as a Chief Scientific Officer of Covalon Technologies Ltd., since December 21, 2004. Dr. DiTizio is a coinventor of Covalon technologies and a cofounder of the company. He has degrees in science from the University of Toronto as a Biochemistry Specialist. Dr. DiTizio completed his Master degree in liposome drug delivery. His graduate research involved the application of polymer chemistry and drug delivery in pursuit of novel materials and processes that currently comprise the core of Covalons intellectual property. Dr. DiTizio holds several US and European patents.
Age: 48 Founder Since 2004
The company has return on total asset (ROA)
of (3.14) %
which means that it has lost $3.14 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (8.57) %
meaning that it generated substantial loss on money invested by shareholders.
Covalon Technologies Ltd. researches, develops, manufactures, markets, and licenses medical solutions in the areas of advanced wound care, infection management, and surgical procedures worldwide. Covalon Technologies Ltd (COV) is traded on TSX Venture Exchange in Canada. It is located in Mississauga, ON LW S and employs 8 people.